ROSETI, CRISTINA
 Distribuzione geografica
Continente #
NA - Nord America 1.431
EU - Europa 1.089
AS - Asia 157
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 2
SA - Sud America 1
Totale 2.689
Nazione #
US - Stati Uniti d'America 1.431
IT - Italia 747
UA - Ucraina 120
SE - Svezia 84
TR - Turchia 79
IE - Irlanda 54
VN - Vietnam 47
DE - Germania 32
CN - Cina 27
GB - Regno Unito 24
EU - Europa 9
FR - Francia 7
CZ - Repubblica Ceca 5
AT - Austria 4
BE - Belgio 3
FI - Finlandia 3
NL - Olanda 3
AU - Australia 2
HK - Hong Kong 2
IN - India 2
CH - Svizzera 1
CL - Cile 1
ES - Italia 1
MD - Moldavia 1
Totale 2.689
Città #
Milan 490
Fairfield 226
Chandler 123
Woodbridge 117
Ashburn 114
Jacksonville 97
Houston 96
Seattle 90
Cambridge 88
Wilmington 79
Nyköping 61
Dearborn 58
Princeton 56
Como 52
Dublin 52
Ann Arbor 47
Izmir 43
Rome 39
Kocaeli 36
Dong Ket 30
New York 12
Ogden 12
Norwalk 11
San Diego 11
London 7
Nanjing 5
Ancona 4
Busto Arsizio 4
Jinan 4
Los Angeles 4
Vienna 4
Washington 4
Beijing 3
Brussels 3
Casnate Con Bernate 3
Dordrecht 3
Frankfurt am Main 3
Garbagnate Milanese 3
Hefei 3
Kilburn 3
Magnago 3
Mentana 3
Padova 3
Redmond 3
Chengdu 2
Chiswick 2
Helsingborg 2
Helsinki 2
Hong Kong 2
New Bedfont 2
Omegna 2
Perugia 2
Prescot 2
Pune 2
Strasbourg 2
Sydney 2
Terzigno 2
Varese 2
Vicenza 2
West Jordan 2
Acton 1
Baotou 1
Boardman 1
Chicago 1
Dicomano 1
Falkenstein 1
Florence 1
Hounslow 1
Lappeenranta 1
Marche 1
Monza 1
Nervesa della Battaglia 1
San Jose 1
Shaoxing 1
Shenyang 1
Tappahannock 1
Valfenera 1
Wandsworth 1
Wenzhou 1
Wuhan 1
Zhengzhou 1
Zurich 1
Totale 2.166
Nome #
A novel GABAergic dysfunction in human Dravet syndrome 139
Acetylcholine receptors from human muscle as pharmacological targets for ALS therapy 137
Neuromuscular magnetic stimulation counteracts muscle decline in ALS patients: results of a randomized, double-blind, controlled study 133
TRP channels expression in Chronic Low Back Pain 124
Changes in the sensitivity of GABAA current rundown to drug treatments in a model of temporal lobe epilepsy 122
Cannabis in Epilepsy: from clinical practice to basic research focusing on the possible role of cannabidivarin 122
Functional aspects of early brain development are preserved in tuberous sclerosis complex (TSC) epileptogenic lesions 117
Adenosine receptor antagonists alter the stability of human epileptic GABAA receptors 113
Modulation of GABAA receptors in the treatment of epilepsy 112
Fractalkine/CX3CL1 modulates GABAA currents in human temporal lobe epilepsy 110
Physiological characterization of human muscle acetylcholine receptors from ALS patients 103
Anomalous levels of Cl- transporters cause a decrease of GABAergic inhibition in human peritumoral epileptic cortex 103
A novel action of lacosamide on GABAA currents sets the ground for a synergic interaction with levetiracetam in treatment of epilepsy 103
Riluzole blocks human muscle acetylcholine receptors 102
Novel approaches to study the involvement of α7-nAChR in human diseases 100
GABAA currents are decreased by IL-1β in epileptogenic tissue of patients with temporal lobe epilepsy: implications for ictogenesis 97
Erythropoietin Increases GABA A Currents in Human Cortex from TLE Patients 95
GABA(A)-current rundown of temporal lobe epilepsy is associated with repetitive activation of GABA(A) "phasic" receptors 91
Functional characterization of Atlantic salmon (Salmo salar L.) PepT2 transporters 82
Characterization of Transport Activity of SLC11 Transporters in Xenopus laevis Oocytes by Fluorophore Quenching 81
Is Betaine a substrate also for GABA transporter 1 (GAT1)? 81
Enhancement of GABA(A)-current run-down in the hippocampus occurs at the first spontaneous seizure in a model of temporal lobe epilepsy 78
The Lepidopteran KAAT1 and CAATCH1: orthologs to understand structure-function relationships in mammalian SLC6 transporters 76
Blockage of A(2A) and A(3) adenosine receptors decreases the desensitization of human GABA(A) receptors microtransplanted to Xenopus oocytes 74
The role of LRRK2 in the modulation of the glutamate transporter EAAT2 in Parkinson's disease 56
Trafficking of the glutamate transporter is impaired in LRRK2-related Parkinson's disease 54
The “www” of Xenopus laevis Oocytes: The Why, When, What of Xenopus laevis Oocytes in Membrane Transporters Research 44
Interview with Cristina Roseti, 2013 Morris-Coole/Epilepsia prize winner (interview by Gary Mathern and Astrid Nehlig) 37
Co-occurring WARS2 and CHRNA6 mutations in a child with a severe form of infantile parkinsonism 35
Betaine-The dark knight of the brain 21
The interaction of bile acids with dopamine transporter heterologously expressed in Xenopus laevis oocytes 12
Totale 2.754
Categoria #
all - tutte 10.898
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.898


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019146 0 0 0 0 0 0 0 0 0 0 54 92
2019/2020564 22 28 35 111 40 77 75 61 47 29 12 27
2020/2021438 10 36 12 33 27 29 36 26 60 70 53 46
2021/2022308 44 36 6 18 9 4 35 18 26 27 49 36
2022/2023424 39 5 40 14 34 82 12 68 64 25 24 17
2023/2024812 131 144 139 146 162 40 7 12 18 8 5 0
Totale 2.754